The Effect of Serum Ferritin in irAE

Clinical trial NCT06702566 · RECRUITING

Trial details

NCT number: NCT06702566
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Immune-related Adverse Event Malignant Solid Tumors Acute Leukemia Serum Ferritin

Start date: 2024-07-04
Primary completion: 2026-07-16
Enrollment: 1500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.